Philips expands access to hemodynamics at point-of-care for real-time blood flow assessment on Handheld Ultrasound – Lumify
February 09 2022 - 9:00AM
Philips expands access to hemodynamics at point-of-care for
real-time blood flow assessment on Handheld Ultrasound – Lumify
February 9, 2022
- Philips point-of-care ultrasound technology now includes Pulse
Wave Doppler for all physicians – from cardiologists and
radiologists to emergency care – to quickly assess hemodynamics in
cardiac function anytime, anywhere
- Lumify is also the first and only handheld ultrasound with
B-lines software and smart algorithms to enhance heart and lung
assessment in severe COVID cases and more
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced it has expanded its ultrasound portfolio with advanced
hemodynamic assessment and measurement capabilities on its handheld
point-of-care ultrasound – Lumify. With the addition of Pulse Wave
Doppler [1], Philips has greatly expanded the utility of its
Handheld Ultrasound – Lumify – enabling clinicians to quantify
blood flow in a wide range of point-of-care diagnostic applications
– including cardiology, vascular, abdominal, urology, obstetrics
and gynecology. Also new to Lumify are obstetric measurements to
help in early assessment of gestational age and the identification
of high-risk pregnancies.
Point-of-care hemodynamicsPulse Wave Doppler
ultrasound provides clinicians with more information, in addition
to 2D and color imaging, to assess hemodynamic patterns to
differentiate between arterial and venous blood flow and quantify
hemodynamic function. The resulting hemodynamic measurements
can enhance diagnostic confidence and timely clinical
decision-making in virtually any care setting, including cardiology
and emergency medicine. With these latest features, Philips’
easy-to-use fully integrated handheld ultrasound system – Lumify –
brings together imaging tools across ultrasound platforms,
leveraging the company’s expertise in cardiology and radiology. The
Lumify system also provides clinicians with advanced analysis
software and reporting tools, and access to tele-ultrasound
capabilities (Lumify with Collaboration Live powered by Reacts) for
live communication support to connect clinicians around the globe
for real-time collaboration.
“By applying Philips’ expertise in cardiovascular care, imaging
and patient monitoring to Philips Handheld Ultrasound – Lumify – we
are committed to deliver a dedicated, innovative point-of-care
portfolio, enabling clinicians to quickly assess hemodynamics –
including cardiovascular function, organ perfusion and fetal
assessment – in a daily routine, to identify abnormalities and
intervene quickly,” said Matthijs Groot Wassink, General Manager of
Point of Care Ultrasound at Philips. “With the addition of Pulse
Wave Doppler and enhanced obstetrics measurements, we have
increased the number of markers on which diagnoses can be made, to
deliver high quality imaging and enhance the evaluation and
effectiveness of treatment in real-time.”
“Having Color Flow Doppler (CFD) and Pulse Wave Doppler on a
handheld device is game changing, allowing clinicians to take
point-of-care ultrasound examinations to the next level,” said Dr.
Robert Jones, Professor of Emergency Medicine at the MetroHealth
System, Cleveland, Ohio in the U.S.A. Dr. Jones will discuss the
clinical advantages and benefits of integrating CFD and Pulse Wave
Doppler into the point-of-care ultrasound evaluation of acutely ill
and injured patients in the Emergency Department in an upcoming
webinar.
Philips B-lines software enhances heart and lung
assessments in handheld ultrasoundIn addition to adding
Pulse Wave Doppler for hemodynamics, Philips is the first and only
point-of-care ultrasound solution with B-lines (B-line
quantification tool for ultrasound lung imaging) software and
intelligent algorithms to enhance heart and lung assessments, which
is critical when dealing with severe COVID cases. The pandemic has
shown the relevance of lung ultrasound in the diagnosis and
treatment of pneumonia, one of the most common complications of
COVID-19. AI-enhanced automated algorithms looking for B-lines in
lung fluid can help provide more objective data and
interpretation.
Increased access to quality careThe continuous
scanning, performance and portability of Philips Handheld
Ultrasound – Lumify – brings a full diagnostic solution to care
professionals at the bedside; both in and outside of the hospital.
The innovative technology is also in widespread use in
community-based mother and child care programs, providing access to
quality healthcare for underserved communities worldwide, including
a program in Kenya driven by the Philips Foundation to
educate midwives to deliver ultrasound-based antenatal pregnancy
screening in village clinics, while receiving telehealth support
from radiologists at distance.
For more information on the award-winning Philips Handheld
Ultrasound – Lumify – and its tele-ultrasound capabilities (Lumify
with Collaboration Live powered by Reacts), visit Philips
point-of-care ultrasound for the latest on high-quality portable
imaging.
[1] Pulse Wave Doppler measurement is currently available on the
Android Lumify app. Availability on the Apple iOS/ iPad iOS Lumify
app is scheduled for the future.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel. : +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2021 sales of EUR 17.2 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Man undergoing ultrasound in ED
- Product shot of Philips Lumify handheld ultrasound
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (BIT:1PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024